134
Participants
Start Date
March 31, 2011
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Wosulin (N or 70/30 with R)
Basal bolus conventional Insulin viz. Wosulin (N or 70/30 with R) to be injected subcutaneously.
Novolin® (N or 70/30 with R)
Basal bolus conventional Insulin viz. Novolin® (N or 70/30 with R) to be injected subcutaneously.
Endocrine & Metabolic Consultants, Rockville
Ormond Medical Arts Pharmaceutical Research Center, Ormond Beach
International Clinical Research - US, LLC, Sanford
International Research Associates, Hialeah
The Center for Diabetes and Endocrine Care, Hollywood
Baptist Diabetes Associates, PA, Miami
Suncoast Clinical Research, New Port Richey
Suncoast Clinical Research, Palm Harbor
University Diabetes & Endocrine Association, Chattanooga
Kentucky Diabetes Endocrinology Center, Lexington
Alzohaili Medical Consultants, Dearborn
Cotton-O'Neil Clinical Research Center, Diabetes & Endocrinology, Topeka
Sergio Rovner, MD, El Paso
Optimum Clinical Research, Inc., Salt Lake City
University Clinical Investigators, Inc. dba Diabetes Research Center, Tustin
Dr Sanjay Kalra, Karnāl
Diabetes Thyroid &Endocrine Centre, Jaipur
Bhandari's Clinic, Jaipur
Dia Care - A Complete Diabetes Care Centre, Ahmedabad
Dr Sharad Pendsey, Nagpur
Dr Rakesh Sahay, Hyderabad
Dr Mala Dharmalingam, Bangalore
Bangalore Diabetes Hospital, Bangalore
ActivMed Practices and Research, Haverhill
ActivMed Practices and Research, Rochester
Lead Sponsor
Wockhardt
INDUSTRY